Executives
-
Van Plew Daniel PEVP & General Mgr, Industrial -
Stahl NeilEVP Research and Development
-
Pitofsky JasonVP Controller
-
Murphy Andrew JEVP Research
-
Mccourt MarionEVP Commercial
-
Larosa Joseph JEVP General Counsel and Secret
-
Fenimore Christopher R.SVP Finance & CFO
-
Schleifer Leonard SBd. Co-Chair, President & CEO
-
Yancopoulos GeorgeBd. Co-Chair, President & CSO
-
Landry Robert EEVP Finance CFO
?
Yancopoulos George
Bd. Co-Chair, President & CSO
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK
1226690
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
0
Price per Share :
$703.43
Equivalence :
$0.0
Transaction History
-
G0.0 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/29/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
G18,148 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/29/24
-
Footnotes
-
-
Footnotes:No footnote found.
-
S886,272 Shares After TransactionValue : $855,864,007.68Sold $107,191.59Transaction Date : 05/15/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.#2 Represents volume-weighted average price of sales of 111 shares of Company stock on May 15, 2024 at prices ranging from $965.58 to $965.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#3 Represents volume-weighted average price of sales of 782 shares of Company stock on May 15, 2024 at prices ranging from $966.04 to $966.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#4 Represents volume-weighted average price of sales of 1,428 shares of Company stock on May 15, 2024 at prices ranging from $967.07 to $967.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
-
S885,490 Shares After TransactionValue : $855,640,132.10Sold $755,638.78Transaction Date : 05/15/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.#2 Represents volume-weighted average price of sales of 111 shares of Company stock on May 15, 2024 at prices ranging from $965.58 to $965.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#3 Represents volume-weighted average price of sales of 782 shares of Company stock on May 15, 2024 at prices ranging from $966.04 to $966.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#4 Represents volume-weighted average price of sales of 1,428 shares of Company stock on May 15, 2024 at prices ranging from $967.07 to $967.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.
-
S884,062 Shares After TransactionValue : $855,285,781.90Sold $1,381,518.60Transaction Date : 05/15/24
-
Footnotes
-
-
Footnotes:#1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.#2 Represents volume-weighted average price of sales of 111 shares of Company stock on May 15, 2024 at prices ranging from $965.58 to $965.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#3 Represents volume-weighted average price of sales of 782 shares of Company stock on May 15, 2024 at prices ranging from $966.04 to $966.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.#4 Represents volume-weighted average price of sales of 1,428 shares of Company stock on May 15, 2024 at prices ranging from $967.07 to $967.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.